Baxter Total Long-Term Assets 2010-2025 | BAX

Baxter total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Baxter total long-term assets for the quarter ending March 31, 2025 were $14.269B, a 22.4% decline year-over-year.
  • Baxter total long-term assets for 2024 were $16.929B, a 9.35% decline from 2023.
  • Baxter total long-term assets for 2023 were $18.676B, a 7.89% decline from 2022.
  • Baxter total long-term assets for 2022 were $20.276B, a 17.74% decline from 2021.
Baxter Annual Total Long-Term Assets
(Millions of US $)
2024 $16,929
2023 $18,676
2022 $20,276
2021 $24,649
2020 $11,608
2019 $10,690
2018 $9,761
2017 $9,848
2016 $8,972
2015 $9,166
2014 $15,976
2013 $15,029
2012 $11,130
2011 $10,423
2010 $9,500
2009 $9,083
Baxter Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $14,269
2024-12-31 $16,929
2024-09-30 $17,812
2024-06-30 $17,719
2024-03-31 $18,388
2023-12-31 $18,676
2023-09-30 $18,622
2023-06-30 $19,680
2023-03-31 $20,192
2022-12-31 $20,276
2022-09-30 $20,155
2022-06-30 $23,949
2022-03-31 $24,543
2021-12-31 $24,649
2021-09-30 $11,640
2021-06-30 $11,678
2021-03-31 $11,610
2020-12-31 $11,608
2020-09-30 $11,065
2020-06-30 $10,899
2020-03-31 $10,742
2019-12-31 $10,690
2019-09-30 $10,089
2019-06-30 $10,326
2019-03-31 $10,263
2018-12-31 $9,761
2018-09-30 $9,819
2018-06-30 $9,688
2018-03-31 $9,934
2017-12-31 $9,848
2017-09-30 $10,093
2017-06-30 $9,259
2017-03-31 $9,026
2016-12-31 $8,972
2016-09-30 $9,206
2016-06-30 $9,159
2016-03-31 $9,333
2015-12-31 $9,166
2015-09-30 $9,034
2015-06-30 $15,518
2015-03-31 $15,127
2014-12-31 $15,976
2014-09-30 $15,932
2014-06-30 $16,142
2014-03-31 $15,873
2013-12-31 $15,029
2013-09-30 $15,653
2013-06-30 $11,566
2013-03-31 $11,504
2012-12-31 $11,130
2012-09-30 $10,720
2012-06-30 $10,398
2012-03-31 $10,667
2011-12-31 $10,423
2011-09-30 $9,841
2011-06-30 $9,932
2011-03-31 $9,652
2010-12-31 $9,500
2010-09-30 $9,423
2010-06-30 $9,112
2010-03-31 $9,151
2009-12-31 $9,083
2009-09-30 $8,890
2009-06-30 $8,671
2009-03-31 $8,263
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.652B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.564B 27.96
Boston Scientific (BSX) United States $154.721B 38.73
Stryker (SYK) United States $149.011B 31.16
EssilorLuxottica (ESLOY) France $125.383B 0.00
Medtronic (MDT) Ireland $110.530B 15.67
Lonza Group Ag (LZAGY) Switzerland $50.919B 0.00
Haleon (HLN) United Kingdom $46.856B 26.72
ResMed (RMD) United States $37.567B 28.22
GE HealthCare Technologies (GEHC) United States $34.277B 16.27
Agilent Technologies (A) United States $33.923B 22.11
Terumo (TRUMY) Japan $27.568B 35.81
Koninklijke Philips (PHG) Netherlands $23.187B 16.27
Insulet (PODD) United States $21.804B 85.59
Zimmer Biomet Holdings (ZBH) United States $18.151B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $13.231B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.625B 23.06
Lantheus Holdings (LNTH) United States $5.586B 14.09
Prestige Consumer Healthcare (PBH) United States $4.010B 17.91
Perrigo (PRGO) Ireland $3.653B 9.26
Haemonetics (HAE) United States $3.592B 16.36
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.330B 27.68
ICU Medical (ICUI) United States $3.216B 23.72
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.941B 13.35
LeMaitre Vascular (LMAT) United States $1.862B 41.62
AtriCure (ATRC) United States $1.628B 0.00
AdaptHealth (AHCO) United States $1.271B 12.90
Acuren (TIC) United States $1.252B 0.00
Green Thumb Industries (GTBIF) United States $1.120B 25.19
Neogen (NEOG) United States $1.040B 13.31
BioLife Solutions (BLFS) United States $1.020B 0.00
Phibro Animal Health (PAHC) United States $1.018B 13.02
Kestra Medical Technologies (KMTS) United States $0.919B 0.00
InMode (INMD) Israel $0.889B 8.96
CeriBell (CBLL) United States $0.697B 0.00
Owens & Minor (OMI) United States $0.644B 5.34
Maravai LifeSciences Holdings (MRVI) United States $0.606B 0.00
Evolus (EOLS) United States $0.600B 0.00
Curaleaf Holdings (CURLF) Canada $0.551B 0.00
Valneva SE (VALN) France $0.489B 0.00
Capricor Therapeutics (CAPR) United States $0.465B 0.00
Surmodics (SRDX) United States $0.416B 0.00
Tilray Brands (TLRY) Canada $0.415B 0.00
VAREX IMAGING (VREX) United States $0.352B 12.94
SNDL (SNDL) Canada $0.328B 0.00
Quanterix (QTRX) United States $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Sanuwave Health (SNWV) United States $0.283B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.03
Cerus (CERS) United States $0.260B 0.00
Sanara MedTech (SMTI) United States $0.252B 0.00
ZimVie (ZIMV) United States $0.251B 11.39
Cresco Labs (CRLBF) United States $0.250B 0.00
Brainsway (BWAY) Israel $0.248B 65.50
Aurora Cannabis (ACB) Canada $0.239B 71.00
Biote (BTMD) United States $0.234B 6.58
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.226B 0.00
Omeros (OMER) United States $0.195B 0.00
TriSalus Life Sciences (TLSI) United States $0.192B 0.00
Organigram Global (OGI) Canada $0.188B 0.00
High Tide (HITI) Canada $0.187B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
Verano Holdings (VRNOF) United States $0.175B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.136B 0.00
FitLife Brands (FTLF) United States $0.120B 14.79
Jin Medical (ZJYL) China $0.102B 0.00
Veru (VERU) United States $0.096B 0.00
Fonar (FONR) United States $0.089B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.080B 0.00
Zynex (ZYXI) United States $0.079B 0.00
TerrAscend (TSNDF) Canada $0.079B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.065B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Nephros (NEPH) United States $0.045B 60.57
United-Guardian (UG) United States $0.038B 13.18
Modular Medical (MODD) United States $0.035B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00